A disproportionality analysis of differences in hypersensitivity reactions to iodinated contrast media using the FDA adverse event reporting system (FAERS)

OBJECTIVE: To compare the disproportionality of hypersensitivity reactions (HSRs) associated with clinically used iodinated contrast media (ICMs) for enhanced patient safety. MATERIALS AND METHODS: We analyzed ICM-related HSR reports from the FDA Adverse Event Reporting System (FAERS) database between the Q1 of 2004 and the Q4 of 2024. Disproportionality analyses were performed to evaluate ICM-related HSR reporting odds ratio and to compare reporting rates of specific HSR subtypes across age, sex, and geographical subgroups. RESULTS: Among 22,375,298 adverse event reports retrieved, 7,515 cases were identified as ICM-induced HSRs. All the studied ICMs were associated with over-reporting frequencies of HSRs, with iopromide showing the highest reporting odds ratio (ROR = 214.11, 95% confidence interval (CI) 197.07 - 232.64). Iopromide and ioversol (ROR = 104.58, 95% CI 93.31 - 117.22) were more likely associated with angioedema than other ICMs, particularly in males and the 45 - 65 age group. Iodixanol (ROR = 17.23, 95% CI 7.95 - 37.34) was associated with the largest disproportionality for severe cutaneous adverse reactions (SCARs), while iodixanol, iopamidol (ROR = 11.90, 95% CI 9.13 - 15.52), and iohexol (ROR = 9.37, 95% CI 7.65 - 11.46) were more likely associated with SCAR than other ICMs, particularly in the 45 - 65 age group. Regarding anaphylactic shock, iopamidol (ROR = 117.18, 95% CI 103.13 - 133.14) and ioversol (ROR = 83.91, 95% CI 74.68 - 133.14) presented a higher disproportionality, especially in males and seniors aged > 65 years. CONCLUSION: The disproportionality signal profiles of ICM-related HSRs vary significantly across specific agents and are influenced by age and sex.

Authors

Publication Details

Journal
International Journal of Clinical Pharmacology and Therapeutics
Published
2026-11-18
DOI
https://doi.org/10.5414/cp205001
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A disproportionality analysis of differences in hypersensitivity reactions to iodinated contrast media using the FDA adverse event reporting system (FAERS)

Xin‐Ran Qiu, Daoli Jiang, Jia Han, Zhen Feng
3 links
International Journal of Clinical Pharmacology and Therapeutics
Pharmacovigilance and Adverse Drug Reactions
article

A disproportionality analysis of differences in hypersensitivity reactions to iodinated contrast media using the FDA adverse event reporting system (FAERS)

Xin‐Ran Qiu, Daoli Jiang, Jia Han, Zhen Feng
article en

Abstract

OBJECTIVE: To compare the disproportionality of hypersensitivity reactions (HSRs) associated with clinically used iodinated contrast media (ICMs) for enhanced patient safety. MATERIALS AND METHODS: We analyzed ICM-related HSR reports from the FDA Adverse Event Reporting System (FAERS) database between the Q1 of 2004 and the Q4 of 2024. Disproportionality analyses were performed to evaluate ICM-related HSR reporting odds ratio and to compare reporting rates of specific HSR subtypes across age, sex, and geographical subgroups. RESULTS: Among 22,375,298 adverse event reports retrieved, 7,515 cases were identified as ICM-induced HSRs. All the studied ICMs were associated with over-reporting frequencies of HSRs, with iopromide showing the highest reporting odds ratio (ROR = 214.11, 95% confidence interval (CI) 197.07 - 232.64). Iopromide and ioversol (ROR = 104.58, 95% CI 93.31 - 117.22) were more likely associated with angioedema than other ICMs, particularly in males and the 45 - 65 age group. Iodixanol (ROR = 17.23, 95% CI 7.95 - 37.34) was associated with the largest disproportionality for severe cutaneous adverse reactions (SCARs), while iodixanol, iopamidol (ROR = 11.90, 95% CI 9.13 - 15.52), and iohexol (ROR = 9.37, 95% CI 7.65 - 11.46) were more likely associated with SCAR than other ICMs, particularly in the 45 - 65 age group. Regarding anaphylactic shock, iopamidol (ROR = 117.18, 95% CI 103.13 - 133.14) and ioversol (ROR = 83.91, 95% CI 74.68 - 133.14) presented a higher disproportionality, especially in males and seniors aged > 65 years. CONCLUSION: The disproportionality signal profiles of ICM-related HSRs vary significantly across specific agents and are influenced by age and sex.

International Journal of Clinical Pharmacology and Therapeutics
Good health and well-being
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon